TAZ Antikörper (C-Term)

Produktnummer ABIN185489

Produktdetails anti-TAZ Antikörper

Target: TAZ (Tafazzin (TAZ))

Bindungsspezifität: C-Term

Reaktivität: Human

Wirt: Ziege

Klonalität: Polyklonal

Konjugat: Dieser TAZ Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA

Verwendungszweck: Tafazzin

Sequenz: HLKTQAEQLH NH

Spezifität: This antibody is expected to recognise isoforms 1to 4 (NP_000107.1, NP_851828.1, NP_851829.1, NP_851830.1, respectively).

Kreuzreaktivität: Hund, Human, Maus, Ratte

Aufreinigung: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Güteklasse: Verified

Immunogen: Peptide with sequence C-HLKTQAEQLHNH, from the C Terminus of the protein sequence according to NP_000107.1, NP_851828.1, NP_851829.1, NP_851830.1.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise:

Western Blot: Approx 28 kDa band observed in Human Heart lysates (calculated MW of 33.5 kDa according to NP_000107.1, 30.2 kDa according to NP_851828.1, 31.7 kDa according to NP_851829.1 and 28.5 according to NP_851830.1). Recommended concentration: 0.3-1.0

Peptide ELISA: antibody detection limit dilution 1:32000.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.5 mg/mL

Buffer: Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Minimize freezing and thawing.

Lagerung: -20 °C

Informationen zur Lagerung: Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.

Details zu TAZ

Target: TAZ (Tafazzin (TAZ))

Andere Bezeichnung: TAZ (TAZ Produkte)

Synonyme: wu:fb39f12 antikoerper, zgc:91803 antikoerper, MGC54019 antikoerper, TAZ antikoerper, taz antikoerper, GB11956 antikoerper, Afu2g13960 antikoerper, BTHS antikoerper, CMD3A antikoerper, EFE antikoerper, EFE2 antikoerper, G4.5 antikoerper, LVNCX antikoerper, Taz1 antikoerper, 5031411C02Rik antikoerper, 9130012G04Rik antikoerper, AW107266 antikoerper, AW552613 antikoerper, tafazzin antikoerper, tafazzin L homeolog antikoerper, tafazzin homolog antikoerper, TAZ antikoerper, taz antikoerper, taz.L antikoerper, LOC550948 antikoerper, AFUA_2G13960 antikoerper, AOR_1_318014 antikoerper, Tsp_06712 antikoerper, Taz antikoerper

Hintergrund: TAZ, tafazzin (cardiomyopathy, dilated 3A (X-linked) endocardial fibroelastosis 2 Barth syndrome) , HGNC:11577, BTHS, CMD3A, EFE, EFE2, G4.5, XAP-2 , OTTHUMP00000061673, cardiomyopathy, dilated 3A (X-linked), tafazzin, XX-FW83563B9.3, FLJ27390, Taz1, LVNC

Gen-ID: 6901

NCBI Accession: NP_000107, NP_851828, NP_851829, NP_851830